Kurome Therapeutics closes $15 million Series A financing
Funding to develop targeted kinase inhibitors for treatment of hematopoietic cancers Kurome Therapeutics, a preclinical stage company dedicated to developing ...
Tag: hematopoietic cancers
POPULAR NEWS
-
Sperm MicroRNAs: Crucial Mediators of Paternal Exercise Capacity Transmission
-
Stinkbug Leg Organ Hosts Symbiotic Fungi That Protect Eggs from Parasitic Wasps
-
New Study Suggests ALS and MS May Stem from Common Environmental Factor
-
New Study Indicates Children’s Risk of Long COVID Could Double Following a Second Infection – The Lancet Infectious Diseases